Quote | Omega Therapeutics Inc. (NASDAQ:OMGA)
Last: | $2.58 |
---|---|
Change Percent: | -2.54% |
Open: | $2.83 |
Close: | $2.58 |
High: | $3 |
Low: | $2.56 |
Volume: | 394,181 |
Last Trade Date Time: | 05/03/2024 03:00:00 am |
News | Omega Therapeutics Inc. (NASDAQ:OMGA)
2024-04-25 17:31:10 ET Gainers: Alphabet ( GOOGL ) +15% . Alphabet ( GOOG ) +15% . Exponent ( EXPO ) +13% . Columbia Sportswear ( COLM ) +8% . SPS Commerce ( SPSC ) +6% . Losers: Intel Corporation ( INTC )...
CAMBRIDGE, Mass., April 23, 2024 (GLOBE NEWSWIRE) -- Omega Therapeutics, Inc. (Nasdaq: OMGA) (“Omega”), a clinical-stage biotechnology company pioneering the development of a new class of programmable epigenomic mRNA medicines, today announced it will present a poster at the America...
Message Board Posts | Omega Therapeutics Inc. (NASDAQ:OMGA)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Omega Therapeutics Inc. Company Name:
OMGA Stock Symbol:
NASDAQ Market:
CAMBRIDGE, Mass., April 23, 2024 (GLOBE NEWSWIRE) -- Omega Therapeutics, Inc. (NASDAQ:OMGA) ("Omega"), a clinical-stage biotechnology company pi...
CAMBRIDGE, Mass., April 23, 2024 (GLOBE NEWSWIRE) -- Omega Therapeutics, Inc. (Nasdaq: OMGA) (“Omega”), a clinical-stage biotechnology company pioneering the development of a new class of programmable epigenomic mRNA medicines, today announced it will present a poster at the America...
MYC-directed epigenomic controller exerts anti-tumor effect in preclinical models of EGFR inhibitor-resistant NSCLC regardless of underlying resi...